Mar. 23, 2023
Source: Boehringer Ingelheim news release
DULUTH, Ga. - Boehringer Ingelheim Animal Health USA Inc. announced today the appointment of Jean Claude Chevez, DVM as the new Executive Director of the U.S. Swine and Poultry Businesses.
Chevez is a 20-year veteran of Boehringer Ingelheim. He has served as Associate Director of the Animal Health Business for Central America and the Caribbean, leading the Pets and Livestock Businesses, since 2020. Previously, he led the company's Swine and Avian Businesses in Mexico and has held several technical roles across livestock species. Chevez earned his degree in veterinary medicine from the Universidad Nacional Autónoma de México (UNAM) and worked as a production manager in both the swine and poultry industries prior to joining Boehringer Ingelheim.
"Jean Claude's long tenure in both the swine and poultry industries provides him a unique understanding of the needs of producers and veterinarians and how Boehringer Ingelheim can best support their efforts to optimize animal health and performance," said Steve Boren, Vice President of Livestock and Equine at Boehringer Ingelheim Animal Health USA Inc. "I am confident that this perspective - along with Jean Claude's background as a veterinarian and experience in the global industry - will be beneficial as we continue our commitment to enhancing swine and poultry health."
About Boehringer Ingelheim Animal Health USA
Boehringer Ingelheim Animal Health is working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals. For veterinarians, pet owners, producers, and governments in more than 150 countries, we offer a large and innovative portfolio of products and services to improve the health and well-being of companion animals and livestock.
As a global leader in the animal health industry and as part of the family-owned Boehringer Ingelheim, we take a long-term perspective. The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. By using the synergies between our Animal Health and Human Pharma businesses and by delivering value through innovation, we enhance the health and well-being of both.
Boehringer Ingelheim Animal Health has deep roots in the U.S. From a start in St. Joseph, Missouri, more than 100 years ago, it has grown to encompass seven sites. Boehringer Ingelheim Animal Health's portfolio contains widely used and well-respected vaccines, parasite-control products and therapeutics for pets, horses and livestock.